Companion Animals

Cushing's Disease in Dogs: Managing Hyperadrenocorticism

Cushing's disease (hyperadrenocorticism) is one of the most common endocrine disorders in middle-aged to older dogs, causing significant welfare impacts through its symptoms and treatment side effects.

Key Facts

Welfare Considerations

Cushing's disease causes a broad and progressive deterioration in quality of life. Muscle weakness makes movement uncomfortable; skin fragility causes painful lesions; chronic infections are uncomfortable and distressing; and excessive thirst and urination disrupt normal routines and sleep. The pot-bellied, lethargic, hair-loss presentation is often incorrectly attributed to normal ageing, delaying diagnosis and treatment. Medical management with trilostane requires careful monitoring — both underdosing (inadequate control) and overdosing (triggering acute Addisonian crisis) carry significant welfare risks. Dogs on treatment require regular ACTH stimulation test monitoring and owners must be educated to recognise signs of over-suppression.

What You Can Do